US Patent Issued on May 26 for "Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitors" (Belgian, Spanish Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,376, issued on May 26.

"Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitors" was invented by Erik D'Hondt (Bazel, Belgium) and Miguel Angel Molina-Vila (Badalona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods for treating cancer. More particularly, the disclosure relates to use of chimeric non-natural synthetic proteins, in combination with non-tyrosine targeting kinase inhibitors (NTKIs), in treating cancer and preventing intrinsic and/or acquired resistance to NTKIs."

The patent was filed on Nov. 6, 2020, under Application No. 17/773,741....